The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.
Noncardiac vascular disease in rheumatoid arthritis: Increase in venous thromboembolic events?†
Article first published online: 29 DEC 2011
Copyright © 2012 by the American College of Rheumatology
Arthritis & Rheumatism
Volume 64, Issue 1, pages 53–61, January 2012
How to Cite
Bacani, A. K., Gabriel, S. E., Crowson, C. S., Heit, J. A. and Matteson, E. L. (2012), Noncardiac vascular disease in rheumatoid arthritis: Increase in venous thromboembolic events?. Arthritis & Rheumatism, 64: 53–61. doi: 10.1002/art.33322
- Issue published online: 29 DEC 2011
- Article first published online: 29 DEC 2011
- Accepted manuscript online: 8 SEP 2011 01:18PM EST
- Manuscript Accepted: 30 AUG 2011
- Manuscript Received: 25 APR 2011
- NIH. Grant Numbers: R01-AR-46849, HL-66216
- National Center for Research Resources, Clinical and Translational Science Award. Grant Number: UL1-RR-024150
- Rochester Epidemiology Project (National Institute on Aging). Grant Number: R01-AG-034676
To investigate the incidence of noncardiac vascular disease in a community-based incidence cohort of patients with rheumatoid arthritis (RA) and compare it to that in the general population and to investigate trends in the incidence of noncardiac vascular disease in patients with RA.
A population-based inception cohort of patients with incident RA between January 1, 1980 and December 31, 2007 in Olmsted County, Minnesota and a cohort of non-RA subjects from the same population base was assembled and followed up until December 31, 2008. Venous thromboembolic, cerebrovascular, and peripheral arterial events were ascertained by medical record review.
The study population included 813 patients with RA with a mean ± SD age of 55.9 ± 15.7 years (68% women) and an average length of followup of 9.6 ± 6.9 years. Compared to non-RA subjects of similar age and sex, patients diagnosed as having RA between 1995 and 2007 had a higher incidence (%) of venous thromboembolism (cumulative incidence ± SE 6.7 ± 1.7 versus 2.8 ± 1.1, respectively; P = 0.005) but similar rates of cerebrovascular and peripheral arterial events. Among patients with RA, the incidence of venous thromboembolic, cerebrovascular, and peripheral arterial events was similar in the 1995–2007 time period compared to the 1980–1994 time period.
Our findings indicate that the incidence of venous thromboembolism is increased in patients with RA compared to non-RA subjects. The incidence of cerebrovascular events and peripheral vascular disease events is similar in patients with RA compared to non-RA subjects. Among patients with RA, the incidence of noncardiac vascular disease has remained stable in recent decades.